MR-61
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MR-61, covering 2025-12-23 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia [Phase 2]